Every night, the online Belgian patent register ('eRegister') receives an update with public data that were entered or generated the preceding day on the Benelux Patent Platform, the computer application with which the Belgian Intellectual Property Office handles the registration, treatment and publication processes for patents and supplementary protection certificates.
Currently, some updates are spread over consecutive nights due to the large, weekly volume of data concerning European patents designating Belgium.
For a European patent it is possible that data about the inventor(s) are missing from the online Belgian patent register. They can be found via the link to the European patent register pending an update of the Belgian patent register.
For European patents with Unitary Effect, the authentic source of information is the European Patent Register : please refer to it.

Patent details

2979701 Title: AGENT ANTITUMORAL COMPRENANT DU CHLORHYDRATE D'IRINOTECAN HYDRATE

The time of generation of the report may vary depending on the number of the selected files and the pages of each file. If the generation of the consolidated PDF file takes long, you may reduce the number of selected files and proceed with the generation of the PDF in batches.
You have not selected any documents

Basic information

Application number:
147736722
WO application number:
JP2014058732
Type:
European patent granted for BE
Status:
Open
Publication number:
2979701
WO publication number:
WO2014157443
1rst applicant's nationality:
Translation language:
EPO publication language:
English
SPC number:

Dates

Filing date:
27/03/2014
Grant date:
26/08/2020
EP publication date:
03/02/2016
WO publication date:
02/10/2014
Claims translation received date:
Translation received date (EP publication B1):
Translation received date (EP publication B2):
Translation received date (EP publication B3):
Registration date:
26/08/2020
EP B1 publication date:
26/08/2020
EP B2 publication date:
EP B3 publication date:
Lapsed date:
Expiration date (if granted and all annual fees paid):
27/03/2034

Applicant

Name:
Taiho Pharmaceutical Co., Ltd.
Legal Form:
From:
26/08/2020
Address:
1-27, Kandanishiki-cho, Chiyoda-ku, Tokyo 101-8444, Japan (JP)
To:

Agent

Name:
POLVERARI Luca
Legal Form:
From:
21/09/2020
Address:
44, rue de la Vallée B.P. 1775, 1017, LUXEMBOURG, Luxembourg (LU)
To:

Inventor

Name:
OKABE, Hiroyuki
Legal Form:
Address:
Tsukuba-shi Ibaraki 300-2611, Japan (JP)

Priority

Priority patent number:
2013066073
Priority date:
27/03/2013
Priority country:
Japan (JP)

Classification

IPC or IDT classification:
A61K 31/4745; A61K 31/506; A61K 31/7072; A61P 35/00; A61P 43/00;

Publication

Bulletin

Bulletin heading:
EP2
Journal edition number:
2020/22
Publication date:
12/10/2020
Description:
Contains data concerning European patents granted and published (B1 publication) for Belgium and for which no translation needed to be filed

European Patent Bulletin

Issue number:
202035
Publication date:
26/08/2020
Description:
Grant (B1)

Annual fee

Annual fee(s) Due Date:
31/03/2026
Annual fee number:
13
Annual fee amount:
275 Euro
Expected payer:
Last annual fee payment date:
14/02/2025
Last annual fee paid number:
12
Last annual fee paid amount:
240 Euro
Payer:
C.P.A.
Filing date Document type Publication Type Document Description Number of pages File Type
21/09/2020 Outgoing Correspondence 1 PDF /1/0/5/3/3/0722033501/docs/147736722_0_outgoingcorrespondence_20200922_085111401.pdf
21/09/2020 Incoming Correspondence (Email) Cover letter 1 PDF /1/0/5/3/3/0722033501/docs/147736722_1_incomingcorrespondenceelectronic_20200922_085112141.pdf
21/09/2020 General Document Declaration of domicile 1 PDF /1/0/5/3/3/0722033501/docs/147736722_2_generaldocument_20200922_085111827.pdf